doi: 10.1152/ajprenal.00174.2007 90 Carraro-LacroixLRMalnicGGirardiAC
Many pharmacies and clinics are now selling peptides like retatrutide, cagrilintide, and other investigational compounds that are not FDA-approved and are still in clinical trials, he noted, explaining that this amounts to experimental medicine being sold directly to consumers without clear dosing standards, safety data, or oversight
A key consideration is the distinction between NAD+ therapies (which often use precursors like NR or NMN) and high-dose Niacin (Vitamin B3), which in some forms can interfere with blood glucose control and may impact the effectiveness of GLP-1 medications
Multi-System Research Utility: Useful in metabolic, endocrine, and energy-regulation laboratory models
By replicating GLP-1s natural activity, Ozempic reduces appetite, increases satiety (the feeling of fullness), and helps control food intake
Wajdlich M, Nowicki M